Shi, Y., Fang, J., Zhou, C., Liu, A., Wang, Y., Meng, Q., Ding, C., Ai, B., Gu, Y., Yao, Y., Sun, H., Guo, H., Zhang, C., Song, X., Li, J., Xu, B., Han, Z., Song, M., Tang, T., Chen, P., Lu, H., Shui, Y., Lou, G., Zhang, D., Liu, J., Liu, X., Liu, X., Gao, X., Zhou, Q., Chen, M., Zhao, J., Zhong, W., Xu, Y., & Wang, M. (2022). immune checkpoint inhibitor‐related adverse events in lung cancer: Real‐world incidence and management practices of 1905 patients in China. Thoracic cancer, 13(3), 412–422. http://access.bl.uk/ark:/81055/vdc_100150592360.0x00001f